Results 1 to 10 of about 5,346,158 (173)

Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]

open access: yesSultan Qaboos University Medical Journal
Blastic plasmacytoid dendritic cell neoplasm is an uncommon, aggressive hematologic neoplasm carrying a poor prognosis with a median survival of one year, making early detection vital. Patients present with a number of characteristic cutaneous manifestations and are treated with chemotherapy and hematopoietic stem cell transplantation, which may ...
Dmitry V Kravchenko   +9 more
doaj   +14 more sources

Blastic plasmacytoid dendritic cell neoplasm [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematodermic neoplasia with frequent cutaneous involvement and leukemic dissemination.
André Lencastre   +5 more
doaj   +17 more sources

Blastic Plasmacytoid Dendritic Cell Neoplasm on the Scalp [PDF]

open access: yesCase Reports in Dermatology, 2011
We describe a 75-year-old Japanese woman with blastic plasmacytoid dendritic cell neoplasm. On her first visit, there were multiple areas of disseminated, elastic hard nodules with multicentric purpura on her scalp.
Sawako Fukushi   +2 more
doaj   +4 more sources

Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]

open access: yesAmerican Journal of Hematology, 2011
ABSTRACTBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that originates from the precursors of plasmacytoid dendritic cells. It commonly presents with findings isolated to the skin although it usually progresses to a leukaemic phase.
Javier, Munoz   +4 more
core   +10 more sources

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent [PDF]

open access: yesHaematologica, 2015
Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from plasmacytoid dendritic cells. There is currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively ...
Fanny Angelot-Delettre   +20 more
doaj   +8 more sources

Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]

open access: yesBlood, 2012
![Figure][1] An 81-year-old man had multiple skin lesions (brown-red plaques on the face, abdomen, and back) and asthenia. There was no hepatosplenomegaly or adenopathy. Despite normal blood count values, the peripheral smear contained blasts (7%).
Fanny Angelot-Delettre
exaly   +4 more sources

Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm [PDF]

open access: yesHaematologica, 2017
Blastic plasmacytoid dendritic cell neoplasm is an aggressive hematologic malignancy with a poor prognosis. No consensus regarding optimal treatment modalities is currently available. Targeting the nuclear factor-kappa B pathway is considered a promising
Laure Philippe   +11 more
doaj   +2 more sources

Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm

open access: yesHaematologica, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that presents with characteristic dark purple skin papules, plaques, and tumors, but may also involve the bone marrow, blood, lymph nodes, and central nervous system ...
Marlise R. Luskin, Andrew A. Lane
doaj   +3 more sources

Juvenile Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesActa Dermato-Venereologica, 2020
is missing (Short communication)
Kinan M. Hayani   +4 more
doaj   +3 more sources

CT findings associated with blastic plasmacytoid dendritic cell neoplasm: a case report

open access: yesActa Radiologica Open, 2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that is frequently misdiagnosed. We present a case of a 53-year-old man diagnosed with blastic plasmacytoid dendritic cell neoplasm with extensive computed tomography ...
Daniel Jeong   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy